Dividend Report Card: Reckitt Benckiser

Published in Company Comment on 7 September 2010

Does the consumer goods company's dividend pass the test?

In the dividend report card series, we analyse financial metrics to begin answering the following questions about a company's dividend:

1. Over time, has this company steadily increased its payouts?

2. How sustainable is the dividend?

3. Does the company have room to further increase the dividend?

For a full explanation of each category, click here for a tutorial.

Today's pupil is Reckitt Benckiser Group (LSE: RB) which has a prospective 3.4% yield, according to Company REFS.

Dividend history

Metric5-Year
Annualised
Growth Rate
Dividend per share24.3%
Diluted earnings per share20.5%

Source: Capital IQ, as of September 7, 2010.

There's no doubt that Reckitt Benckiser's dividend growth rate has been impressive and its doubly encouraging that it's kept pace with earnings per share growth, which is exactly what you want to see. For those reasons, it scores at 5 of 5 in this category.

Sustainability

MetricTrailing
12 Months
Final Grade
Weighting
Report Card
Score
(out of 5)
Interest cover512 times10%5
EPS payout ratio46.8%10%5
FCFE payout ratio47.3%30%5

Source: Capital IQ, as of September 7. 2010.

That interest cover figure isn't a typo -- Reckitt Benckiser generates £512 in operating profit for every £1 it pays in interest expense and has no long-term debt on its books. Add its £653 million cash balance to the mix, and you have a high quality balance sheet that should help sustain the dividend.

The recent £2.5 billion acquisition offer for SSL International (LSE: SSL) will certainly cost a nice chunk of change, but if history is any guide, the company will quickly pay down any debt it may take on from the acquisition. Maynard Paton, Motley Fool Champion Shares PRO advisor, reminded investors of this corporate practice in a recent note: "Between 2006 and 2008, the group spent £3bn on two major acquisitions and all the associated borrowings were paid off by the end of 2009."

Considering the strong balance sheet and adequate earnings and free cash flow cover, Reckitt Benckiser's current dividend looks quite sustainable.

Growth

MetricTrailing
12 Months
Final Grade
Weighting
Report Card
Score
(out of 5)
EPS payout ratio46.8%10%4
FCFE payout ratio47.3%20%4
Sustainable growth rate21.2%10%5

Reckitt Benckiser has all the makings of a great dividend-growth share with payout ratios consistently below 50% and high returns on equity (the five year average is 39.5%).

But investors should also be mindful that the company is actually returning less overall value to shareholders today than in it did in 2008 because of the suspended share repurchase programme.

In 2008, for instance, Reckitt Benckiser repurchased a net £237 million worth of shares and paid £441 million in cash dividends, for a total £678 million returned to shareholders. In the past twelve months, however, the company has issued £154 million in shares (i.e. shareholder dilution) and paid out £718 million in cash dividends, resulting in a net return of just £564 million.

Sure, I'd prefer a dividend to share repurchases any day, but I also don't want to be concerned that the dividend growth is being fueled by a reduction in shareholder returns somewhere else along the line. At this point, that's not completely clear, so I'll be keeping my eye on this facet of Reckitt Benckiser's business in the coming quarters.

Competitors

An "ungraded" section of the dividend report card is to see how a stock's current yield stacks up against its direct competitors. If it's too high relative to competitors' yields, the board could be tempted to slow the growth rate, or vice versa, to bring it more in line with the industry average.

CompanyDividend
Yield*
Procter & Gamble (US)3.2%
Colgate-Palmolive (US)2.8%
Unilever (LSE: ULVR)3.0%

* All trailing yields

Reckitt Benckiser's 3.2% trailing yield is right in-line with its major global competitors, so there should be little internal or external pressure to change the company's approach to dividends.

Pencils down!

With all the numbers in, here's how Reckitt Benckiser's dividend scored:

WeightingCategoryFinal Grade
10%History5
 Sustainability 
10%Interest Cover5
10%EPS Payout Ratio5
30%FCFE Payout Ratio5
 Growth 
10%EPS Payout Ratio4
20%FCFE Payout Ratio4
10%Sustainable growth5
100%Total Score (Out of 5)4.7
 Final GradeA

There's a lot to like about Reckitt Benckiser's dividend -- it's well covered by profits and free cash flow and is backed by a nearly immaculate balance sheet. Its 3.2% trailing yield isn't much above the FTSE 100 average of 3%, but the potential payout growth is what makes Reckitt Benckiser's dividend attractive.

Read more dividend report cards:

> Todd owns shares of Procter & Gamble.

Coming soon: The Motley Fool will be launching a brand new service focussed on dividend investing. Register your interest and you'll be the first to find out the full details.

Share & subscribe

Comments

The opinions expressed here are those of the individual writers and are not representative of The Motley Fool. If you spot any comments that are unsuitable hit the flag to alert our moderators.

F958B 07 Sep 2010 , 5:15pm

Although RB is a good company, the shares are slightly expensive - trading on 16x forward earnings, with earnings forecast to be flat for the next couple of years.
20% annual growth? Not for at least the next couple of years, according to the usually-optimistic analists.

In my experience, good companies at slightly expensive prices eventually disappoint the market and the shares get hammered - and that is the time to buy.

I'd rather have one of the lower-P/E, higher-yield companies that the Fool often mention - GSK, VOD etc - since there is not much expectation built into the share price (bad press about GSK last night and today, yet the shares are up 11p today) and a higher dividend while you wait for a re-rating.
In the case of RB, if I was a shareholder, I'd be concerned about when the market will de-rate the shares.

Even ULVR were selling for about 11x earnings several years ago, but now sell for much more; valuation is on a par with RB nowadays. If you could buy ULVR at 11x earnings, then why should RB be immune to a slip-up and de-rating for a few years?

murphy100 08 Sep 2010 , 7:24pm

F958B

Whilst I accept your comments about RB's overpriced ratings, having owned Reckitt & Coleman >> RB since it was £8.50, it has always been overpriced and has always failed to disappoint!

Perhaps this time is different, but I suspect Buffett's philosophy of owning quality will pull this one through, again.

Unexciting as a pot of bathroom cleaner, but (relatively) safe!

F958B 08 Sep 2010 , 8:57pm

murphy100

Yes, RB seems to manage to hold a persistent premium price - and has done so for many years. I admire the company, but I have yet to see RB trade at even a fair price.
Buffet waits to buy good companies at fair prices. In my book, "fair" means:
1.
No more expensive than the market average.
2.
Less than the long-term market average P/E or about 13x.

Maybe RB won't disappoint, but, knowing how other shares have been hammered after a disappointment, I'd prefer to stick with companies that already have disappointment built-in.
Such companies include AZN, with its past P/E of 9x and a forward (estimated) P/E of 8x.

Disclaimer:
I have a sizeable holding in AZN.
I don't own any RB, but would like to add a sizeable holding in RB if I can buy at a reasonable price. Meanwhile, I wait for they day that the fall from grace, just as I did for AZN, GSK, VOD and others.

Join the conversation

Please take note - some tags have changed.

Line breaks are converted automatically.

You may use the following tags in your post: [b]bolded text[/b], [i]italicised text[/i]. All other tags will be removed from your post.

If you want to add a link, please ensure you type it as http://www.fool.co.uk as opposed to www.fool.co.uk.

Hello stranger

To add your own comment, please login.

Not yet registered? Register now.